Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)

Millennium Pharmaceuticals, Inc. · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
drug-therapy
small cell lung cancer, drug therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 912782
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.